Cerebrospinal Fluid Biomarkers in Multiple System Atrophy Relative to Parkinson’s Disease: A Meta-Analysis

Objective. To investigate the differences of candidate cerebrospinal fluid (CSF) biomarkers associated with multiple system atrophy (MSA) and Parkinson’s disease (PD). Method. Here, a systematic review and meta-analysis were conducted on studies related to CSF biomarkers associated with MSA and PD o...

Full description

Bibliographic Details
Published in:	Behavioural Neurology
Main Authors:	Dan Xie, Ling Feng, Hongyan Huang, Quanzhen Zhao, Pingping Ning, Qiuyan Shen, Haitao Lu, Fang Xu, Yanming Xu
Format:	Article
Language:	English
Published:	Wiley 2021-01-01
Online Access:	http://dx.doi.org/10.1155/2021/5559383

Similar Items

Cerebrospinal Fluid Levels of Chromogranin A in Parkinson’s Disease and Multiple System Atrophy
by: Michaela Kaiserova, et al.
Published: (2021-01-01)

A meta-analysis of the diagnostic utility of biomarkers in cerebrospinal fluid in Parkinson’s disease
by: Chunchen Xiang, et al.
Published: (2022-11-01)

Meta-analysis of cerebrospinal fluid neuron-specific enolase levels in Alzheimer’s disease, Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy
by: Takayuki Katayama, et al.
Published: (2021-10-01)

Cerebrospinal fluid biomarkers in multiple sclerosis
by: Hayrettin Tumani, et al.
Published: (2009-08-01)

Cerebrospinal Fluid Biomarkers in Parkinson’s Disease: A Critical Overview of the Literature and Meta-Analyses
by: Takayuki Katayama, et al.
Published: (2020-07-01)

Integrative Analysis of Metabolome and Proteome in the Cerebrospinal Fluid of Patients with Multiple System Atrophy
by: Nimisha Pradeep George, et al.
Published: (2025-02-01)

Neurofilament Light Chain in Cerebrospinal Fluid and Blood in Multiple System Atrophy: A Systematic Review and Meta-Analysis
by: Silvia Demiri, et al.
Published: (2025-02-01)

Author Correction: A meta-analysis of the diagnostic utility of biomarkers in cerebrospinal fluid in Parkinson’s disease
by: Chunchen Xiang, et al.
Published: (2023-03-01)

Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach
by: Tainá M. Marques, et al.
Published: (2021-11-01)

Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis
by: J. M. Hatcher-Martin, et al.
Published: (2021-11-01)

Potential cerebrospinal fluid metabolomic biomarkers and early prediction model for Parkinson’s disease
by: Yifan Zhang, et al.
Published: (2025-05-01)

Proteomics for Cerebrospinal Fluid Biomarker Identification in Parkinsons Disease: Methods and Critical Aspects
by: Antonio Conti, et al.
Published: (2015-01-01)

Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approach
by: Karin D. van Dijk, et al.
Published: (2010-09-01)

Serum and Cerebrospinal Fluid Cytokine Biomarkers for Diagnosis of Multiple Sclerosis
by: Ekaterina Martynova, et al.
Published: (2020-01-01)

Oligoclonal bands in the cerebrospinal fluid and increased brain atrophy in early stages of relapsing-remitting multiple sclerosis
by: Juan Ignacio Rojas, et al.
Published: (2012-08-01)

Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson's disease diagnosis.
by: Marcia Cristina T Dos Santos, et al.
Published: (2018-01-01)

Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative
by: Brice Laurens, et al.
Published: (2015-08-01)

Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis
by: Franz Felix Konen, et al.
Published: (2022-07-01)

Oxidative Stress Markers in Cerebrospinal Fluid of Newly Diagnosed Multiple Sclerosis Patients and Their Link to Iron Deposition and Atrophy
by: Andrea Burgetova, et al.
Published: (2022-06-01)

The Cerebrospinal Fluid in Multiple Sclerosis
by: Florian Deisenhammer, et al.
Published: (2019-04-01)

Cerebrospinal fluid in multiple sclerosis
by: Rammohan Kottil
Published: (2009-01-01)

Cerebrospinal Fluid Biomarkers of Alzheimer Disease
by: Kseniya V. Nevzorova, et al.
Published: (2025-06-01)

A Prediction Model for Peak Expiratory Flow Derived From Venous Blood Biomarkers and Clinical Factors in Amyotrophic Lateral Sclerosis
by: Xianghua He, et al.
Published: (2022-05-01)

Lipid Metabolism Disorder in Cerebrospinal Fluid Related to Parkinson’s Disease
by: Jiewen Qiu, et al.
Published: (2023-08-01)

Exploring cerebrospinal fluid metabolites, cognitive function, and brain atrophy: Insights from Mendelian randomization
by: Liu Qian, et al.
Published: (2025-08-01)

Constipation in multiple system atrophy: a pilot study in Chinese patients
by: Yalan Chen, et al.
Published: (2023-06-01)

Prediction of Proteins in Cerebrospinal Fluid and Application to Glioma Biomarker Identification
by: Kai He, et al.
Published: (2023-04-01)

The Diagnostic and Differential Diagnosis Utility of Cerebrospinal Fluid α-Synuclein Levels in Parkinson’s Disease: A Meta-Analysis
by: Bo Zhou, et al.
Published: (2015-01-01)

Freezing of gait in Chinese patients with multiple system atrophy: prevalence and risk factors
by: Yalan Chen, et al.
Published: (2023-06-01)

β-synuclein in cerebrospinal fluid as a potential biomarker for distinguishing human prion diseases from Alzheimer’s and Parkinson’s disease
by: Bing Xu, et al.
Published: (2025-02-01)

Cerebrospinal fluid biomarkers for normal pressure hydrocephalus
by: Derya Kaya, et al.
Published: (2023-12-01)

Biomarkers in Cerebrospinal Fluid for the Diagnosis and Monitoring of Gliomas
by: Dimosthenis Papadimitrakis, et al.
Published: (2024-07-01)

Cerebrospinal fluid biomarkers of infantile congenital hydrocephalus.
by: David D Limbrick, et al.
Published: (2017-01-01)

The relationship between myodural bridge, atrophy and hyperplasia of the suboccipital musculature, and cerebrospinal fluid dynamics
by: Heng Yang, et al.
Published: (2023-11-01)

Association between dietary intake and risk of Parkinson’s disease: cross-sectional analysis of survey data from NHANES 2007–2016
by: Ling Liu, et al.
Published: (2023-12-01)

Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis
by: Tilman Robinson, et al.
Published: (2020-11-01)

Serum BDNF as a Potential Biomarker of Alzheimer's Disease: Verification Through Assessment of Serum, Cerebrospinal Fluid, and Medial Temporal Lobe Atrophy
by: Yukiko Mori, et al.
Published: (2021-04-01)

Iron Concentration Does Not Differ in Blood but Tends to Decrease in Cerebrospinal Fluid in Parkinson’s Disease
by: Xiaoli Shen, et al.
Published: (2019-09-01)

The associations of cerebrospinal fluid biomarkers with cognition, and rapid eye movement sleep behavior disorder in early Parkinson’s disease
by: Mingzhu Tao, et al.
Published: (2022-11-01)

Fecal Calprotectin in Parkinson’s Disease and Multiple System Atrophy
by: Jia Wei Hor, et al.
Published: (2022-05-01)